BBA
ABBV icon

Baker Bros. Advisors’s AbbVie ABBV Stock Holding History

Baker Bros. Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,685,994
Closed -$106M – 120
2016
Q4 		$106M Sell
1,685,994
-12,657,364
-88% -$773M 1.04% 12
2016
Q3 		$905M Sell
14,343,358
-30,180
-0.2% -$1.95M 8.21% 3
2016
Q2 		$890M Hold
14,373,538
– – 9.33% 3
2016
Q1 		$821M Hold
14,373,538
– – 8.66% 4
2015
Q4 		$851M Hold
14,373,538
– – 7.05% 4
2015
Q3 		$782M Hold
14,373,538
– – 7.23% 4
2015
Q2 		$966M Buy
+14,373,538
New +$938M 8.47% 4

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Baker Bros. Advisors's ABBV Position: Q1 2017 in Review

Baker Bros. Advisors sold out of AbbVie (ABBV) in Q1 2017, closing a stake of 1,685,994 shares — an estimated $106M sold.

Baker Bros. Advisors first reported a position in ABBV in Q2 2015 and held it in 7 quarters. The position peaked at $966M in Q2 2015. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • Baker Bros. Advisors reported no remaining AbbVie position as of Q1 2017 after selling out during the quarter.
  • Baker Bros. Advisors sold 1,685,994 AbbVie shares in Q1 2017, an estimated $106M.
  • Baker Bros. Advisors first reported a position in AbbVie in Q2 2015 and held it in 7 quarters.
  • Baker Bros. Advisors's AbbVie position peaked at $966M in Q2 2015.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Baker Bros. Advisors's 13F filing for Q1 2017, filed 15 May 2017.